Tracheobronchial stent grafts are used in management of lumen
collapse or to prevent collapse after tracheobronchial reconstruction
procedure, after trauma or lesions, airway obstruction etc.
tracheobronchial stent-graft is a self-expanding stent generally made
of nitinol mesh wire and encapsulated within two ultra-thin layers of
expanded polytetrafluoroethylene (ePTFE). Moreover, number of benign
and malignant conditions can cause tracheobronchial narrowing or
collapse which can lead to symptomatic and life-threatening dyspnea.
Tracheobronchial stent graft system is mainly approved for use in
treatment of in-stent restenosis in venous outflow in hemodialysis
patients. The first tracheobronchial stent graft system ‘Fluency’
was introduced in 2003 by C.R. Bard Inc. In 2005, W. L. Gore &
Associates launched VIABAHN in the U.S. for use in treatment of
tracheobronchial strictures. Both of these systems witnessed positive
response from physicians and patients. Now-a-days, these devices are
available in ling delivery sheaths or catheters necessary for
placement of tracheobronchial stent graft.
Report Overview @
https://www.transparencymarketresearch.com/tracheobronchial-stent-grafts-market.html
Increasing prevalence of chronic lung disorders such as tuberculosis
and benign or malignant tumors are the foremost factor driving the
growth of global tracheobronchial stent grafts market over the
forecast period. Besides, easy and efficient procedure is the other
factor expected to flourish the global tracheobronchial stent grafts
market However, limited product approvals for tracheobronchial stent
grafts in Europe. And alternative treatment options for
tracheobronchial strictures are the important factors limiting the
growth of global tracheobronchial stent grafts market.
Recent approval of Fluency Plus brings new hope to patients suffering
from chronic lung diseases that cause airway obstruction. These
device is expected to gain rapid adoption by patients as it is
minimally invasive procedure and involves less risk that other
approaches used for management of tracheobronchial strictures. The
global market for tracheobronchial stent grafts is expected to grow
significantly with high single digit growth rate over the forecast
period of 2017–2027.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25985
Geographically, tracheobronchial stent grafts market is classified
into regions viz. North America, Latin America, Western Europe,
Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North
America is expected to dominate global tracheobronchial stent grafts
market over the forecast period. Japan is expected to be the second
largest market for tracheobronchial stent grafts. Despite the fact
that tracheobronchial stent graft systems are being used since 2003,
these systems are approved for clinical use only in the U.S., Canada
and Japan. Key player in tracheobronchial stent grafts market is are
trying to obtain regulatory approval in Europe in order to capture
growing patient volume for chronic lung diseases.
So far BARD Peripheral Vascular. Inc. – a subsidiary of C.R. Bard
Inc., and W. L. Gore & Associates are the only player operating
in the global market for tracheobronchial stent graft systems. Bard
offers Fluency and Fluency Plus tracheobronchial stent grafts in
North America and Japan. Some of the other systems such as Symbiot
and Corvita Endoluminal Stent-Graft were being studied in the Europe
but unfortunately they failed to meet required clinical end points
and never came to market.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=25985<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment